Belgium’s Tigenix says heart attack stem cell trial successful – WHTC
|
Belgium's Tigenix says heart attack stem cell trial successful
WHTC BRUSSELS (Reuters) – Belgian biotech group Tigenix said on Monday its medical trial with a novel treatment for patients at risk of heart failure after a coronary attack was successful. The group said patients treated in its PhaseI/II trial of donor … |
